Yijun Yang, Sc.D., Ph.D.

Mar 31, 2021View PDF

Dr. Yang has 20 years of experience in the pharmaceutical industry and held positions at Harvard University and multiple global pharmaceutical companies.

Dr. Yang participated in the clinical development approvals of multiple therapeutics, including INCIVEK® (telaprevir), TORISEL® (temsirolimus) and KANUMA® (sebelipase alfa).